Viatris Reports $634.2 Million Quarterly Loss
The company records $14.7 billion revenue for Q4 ended Dec 31, 2024
Viatris Inc [VTRS] reported $634.2 million loss for Q4 ended Dec 31, 2024, showing a decrease of $688.9 million in the same quarter of the previous year.
The company revealed in its 8-K filing to the SEC dated Feb 27, 2025 that it generated revenue of $14.7 billion for the period, showing a decrease of $687.6 million in the same quarter of the previous year.
Based in Pittsburgh, Pennsylvania, the company reported $0.5 earnings per share for the period, compared to $0.1 in the last quarter.
The company's loss decreased by 1.26 thousand% from $54.7 million in the last quarter.
The revenue decreased 4.46% from $15.4 billion in the same quarter of the previous year.
Related News:
- Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors
- OYSTER POINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oyster Point Pharma, Inc. - OYST
- Viatris Completes Biosimilars Transaction with Biocon Biologics